NIH-funded research R01 grant

TDP-43 mislocalization and modifications in neurodegenerative diseases

Official title: Investigating the role of TDP-43 mislocalization, structure, and post-translational modifications in the neuropathologically heterogeneous TDP-43 proteinopathies

Funded at Indiana University Indianapolis · NIH-11500606 · Data updated 2026-11-12

Researchers will study how TDP-43 protein changes and clumps relate to different brain diseases like Alzheimer's and ALS to better understand why symptoms vary.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startApril 16, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$120,341
NIH project number3R01NS137469-03S1
Project IDNIH-11500606 on NIH RePORTER

Who could benefit from this research

Could help

Adults with or at risk for FTLD-TDP, LATE-NC, Alzheimer's disease dementia, ALS, or related TDP-43 proteinopathies.

Less likely to help

Individuals without TDP-43–related pathology or without access to specialized brain research samples may see limited direct benefit.

What this research studies

This project looks at how TDP-43 protein mislocalizes, changes shape, and undergoes post-translational modifications in patients with neurodegenerative conditions. Using advanced tissue analysis, imaging, and molecular techniques, the team will map different TDP-43 structures to disease subtypes and clinical features. By integrating neuropathology, genetics, and cryo-electron microscopy, they aim to link specific TDP-43 forms with regional brain damage and disease progression. The findings could reveal markers that help classify patients and guide future therapies.

Why it matters

Potential benefit: Better understanding of TDP-43–driven diseases could lead to more precise diagnoses and inform development of targeted treatments.

How similar studies have gone: Previous work shows that different TDP-43 structures and PTMs relate to disease subtypes, supporting potential for new biomarkers and therapies.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Newell, Kathy L — Indiana University Indianapolis
  • Study coordinator: Newell, Kathy L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.